
Dianthus Therapeutics grants stock options to six new employees as inducements under Nasdaq rules.
Dianthus Therapeutics announced inducement grants of stock options to six newly hired non-executive employees. The grants total 87,000 options with a 10-year term and an exercise price of $106.02 per share, vesting over four years. These grants were ...

